# AstraZeneca Dunkerque Production (AZDP) – FDA Inspection, Feb 3, 2022

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-dunkerque-production-azdp/64c14df4-1cf0-40cf-8ed3-2d05ef102946
Source feed: FDA_Inspections

> FDA inspection 1275115 of AstraZeneca Dunkerque Production (AZDP), February 03, 2022. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275115
- Company Name: AstraZeneca Dunkerque Production (AZDP)
- Inspection Date: 2022-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1101056 - 2018-12-21
- [FDA Inspection 961861 - 2015-11-20](https://www.keypedia.com/records/fda_inspections/astrazeneca-dunkerque-production-azdp/5d2047f6-4703-4457-aa42-7c3cfd6b85fa)
- FDA Inspection 839238 - 2013-05-17
- FDA Inspection 560743 - 2009-01-30

Company: https://www.keypedia.com/companies/astrazeneca-dunkerque-production-azdp/581c1e69-c574-45d9-a5e0-a263fc2e4c6c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c